Fullerton Fund Management CO Ltd. Moderna, Inc. Transaction History
Fullerton Fund Management CO Ltd.
- $2.06 Billion
- Q1 2024
A detailed history of Fullerton Fund Management CO Ltd. transactions in Moderna, Inc. stock. As of the latest transaction made, Fullerton Fund Management CO Ltd. holds 78,060 shares of MRNA stock, worth $9.05 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
78,060
Previous 100,050
21.98%
Holding current value
$9.05 Million
Previous $9.95 Million
16.39%
% of portfolio
0.4%
Previous 0.59%
Shares
7 transactions
Others Institutions Holding MRNA
# of Institutions
1,038Shares Held
245MCall Options Held
12.1MPut Options Held
9.36M-
Baillie Gifford & CO44.7MShares$5.18 Billion3.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA39MShares$4.53 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY25.4MShares$2.94 Billion0.06% of portfolio
-
State Street Corp Boston, MA14.5MShares$1.68 Billion0.07% of portfolio
-
Flagship Pioneering Inc. Cambridge, MA9.67MShares$1.12 Billion67.87% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $45.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...